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Skeletal muscle differentiation drives a dramatic downregulation of RNA polymerase III activity 
and differential expression of Polr3g isoforms 
Caitlin McQueen, Gideon L Hughes and Mary E Pownall 
Biology Department, University of York, York YO10 5DD United Kingdom 
 
Abstract 
Gene regulatory networks underpinning skeletal muscle determination and differentiation have 
been extensively investigated, providing molecular insights into how cell lineages are established 
during development. These studies have exclusively focused on the transcriptome downstream of 
RNA polymerase II (Pol II). RNA polymerase III (Pol III) drives the production of tRNAs and other 
small RNAs essential for the flow of genetic information from gene to protein and we have found 
that a specific isoform of a subunit unique to Pol III is expressed early in the myogenic lineage. This 
points to the possibility that additional regulatory networks exist to control the production of Pol 
III transcripts during skeletal muscle differentiation. We describe the differential expression of 
Polr3g and its alternate isoform Polr3gL during embryonic development and using a custom tRNA 
microarray, we demonstrate their distinct activity on the synthesis of tRNA isoacceptors. We show 
that Pol III dependent transcripts are dramatically down-regulated during the differentiation of 
skeletal muscle, as are mRNAs coding for Pol III associated proteins Brf1 and Brf2, while Polr3gL is 
up-regulated alongside contractile protein genes. Forcing Polr3g expression in this context results 
in a partial reversal of myogenic differentiation. 
 
Introduction 
Differential gene expression drives the establishment of distinct cell lineages during development 
and the transcriptional regulation of protein coding genes during this process has been widely 
studied. For instance, the establishment of the myogenic cell lineage requires a set of bHLH 
transcription factors known collectively as myogenic regulatory factors (MRFs) that include myoD, 
myf5, myogenin, and MRF4 (Pownall et al., 2002). These factors are central to a gene regulatory 
network (GRN) that first promotes the proliferation of a progenitor population with myogenic 
potential and later activates the coordinated transcription of skeletal muscle specific genes such as 
those that code for contractile proteins (Fong and Tapscott, 2013; Moncaut et al., 2013).  While 
these studies have focused only on transcription driven by RNA polymerase II (Pol II), the regulation 
of RNA polymerase III (Pol III) activity during myogenesis remains largely unprobed in this context.  
Among other targets, such as U6 and 5S RNAs, Pol III synthesises the tRNAs that decode the Pol II 
mRNAs during protein synthesis; in this way, the interaction between Pol II and Pol III products 
enables the flow of genetic information.  In bacteria, differential expression of tRNA isoacceptors 
(that recognise specific codons) is a mechanism used to control translation of specific proteins (Kane, 
1995). Quantitative analysis of RNA-seq and ChIP-seq data investigating the expression of mRNA and 
tRNA genes in different lineages has revealed a remarkable correlation between the codon demands 
of protein coding genes and the expression of the corresponding anticodon tRNA genes (Gingold et 
al., 2014) (Dittmar et al., 2006). The observation that codon usage changes during development, 
while a stable pool of corresponding anticodon tRNA isoacceptors is maintained, indicates that 
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regulatory mechanisms must exist to stabilise the ‘mRNA-tRNA’ interface (Schmitt et al., 2014) 
(Rudolph et al., 2016). The extent of Pol II /Pol III coordination, that is, the balance of codon demand 
to tRNA supply, is thought to contribute to cellular fitness (Gingold and Pilpel, 2011). For instance, 
the transcriptomes of proliferative and differentiated cells have been shown to actively balance the 
synthesis of specific tRNAs with the codon usage of mRNAs expressed in each state (Gingold et al., 
2014). 
 In contrast to Pol I and Pol II, RNA polymerase III is present in two different isoforms, one of which is 
enriched in proliferative cells, including stem cells and some tumour cell lines (Jin et al., 2016; Wong 
et al., 2011).  The distinct isoforms of Pol III are distinguished by the presence of the small subunit 
Polr3g (RPC32α) or Polr3gL (RPC32β) coded for by different genes (Haurie et al., 2010). The POLR3G 
(g or gL) subunit is unique to Pol III with no corresponding subunit in RNA Polymerase I or Pol II. 
Polr3g isoforms are part of a dissociable tripartite sub-complex with PolR3C (RPC62) and 
PolR3F(RPC39) that recruits Pol III to target genes (Wang and Roeder, 1997)  forming a bridge 
between TFIIIB and the Pol III core enzyme (Boissier et al., 2015). The Polr3g isoform is expressed at 
high levels in proliferative cells and its expression decreases during differentiation (Haurie et al., 
2010; Wong et al., 2011). Consistent with its association with proliferation, Polr3g expression 
increases during cellular transformation in cancer and its overexpression can elicit anchorage 
independent growth. In contrast, Polr3gL expression was not changed during differentiation or 
transformation (Haurie et al., 2010). Polr3g is expressed in undifferentiated human embryonic stem 
(ES) cells and knocking-down Polr3g decreases the expression of pluripotency genes Oct4, Nanog 
and Sox2 with a corresponding increase in differentiation markers, pointing to a role for Polr3g in 
maintaining pluripotency (Wong et al., 2011). miR-1305 has recently been implicated in restricting 
Polr3g during differentiation of pluripotent cells (Jin et al., 2016), supporting the notion that Polr3g 
is a pluripotency factor.   
In this study, we describe the expression of POLR3G genes during the development of Xenopus 
tropicalis and show that the gene product for Polr3g is present as a maternal transcript and protein, 
and that it is expressed zygotically in cells early in the myogenic lineage. Polr3gL is only transcribed 
zygotically and more widely, including in differentiating muscle. We use a custom microarray to 
determine the effect of over expressing Polr3g and Polr3gL on the synthesis of tRNA isoacceptors 
and find the output is different depending on isoform expressed and stage analysed. We drive 
skeletal muscle differentiation in an explant model and find a dramatic down regulation of RNA Pol 
III activity associated with increased expression of Polr3gL. Together our results suggest that the 
differential expression of these two distinct isoforms of Pol III plays a role in the progressive 
establishment of cell fate. 
 
Methods 
Embryological manipulations 
X.tropicalis embryos obtained by in vitro fertilisation were microinjected at the one or two cell stage 
with synthetic mRNA (specific doses are indicated in results and figure legends). Embryos were 
cultured in 5% Modified Ringers Saline until the stage indicated (Nieuwkoop and Faber, 1967). For 
animal cap explants, tungsten needles were used to dissect the animal pole region at late blastula 
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stage (Nieuwkoop and Farber (NF) Stage 8-9) that were cultured until tailbud stage (NF25). For 
dorsal dissections, stage 25 embryos were removed from their vitelline membranes and allowed to 
rest briefly before using mounted tungsten needles to dissect the head and ventral and dorsal 
sections. For collection, animal caps and dissected sections were snap-frozen on dry ice and stored 
at -80˚c until use.  
Cloning and overexpression experiments 
 
Transcripts coding for X.tropicalis Polr3g (XM_002942427) and Polr3gL (XM_012967920) were 
identified in NCBI databases. To determine that the annotated sequences were correctly identified 
as Polr3g and Polr3gL in Xenopus, Polr3g and Polr3gL protein sequences for multiple vertebrate 
model organisms were identified in NCBI and a phylogenetic tree constructed in MegAlign showed 
that the protein sequence for X.tropicalis Polr3g and Polr3gL clustered with the corresponding 
protein in other species (data not shown but extensive phylogeny has been done on these genes 
(Renaud et al., 2014)) . To generate probes for expression analyses of Polr3g and Polr3gL in 
X.tropicalis during development, primers were designed to amplify sequences from unique regions 
of Polr3g and Polr3gL using cDNA derived from X.tropicalis embryos; these products were cloned 
into Promega pGEM T-easy. The same primers were also used for semi-quantitative reverse 
transcriptase (RT)-PCR analysis. The plasmids were sequenced to confirm identity and determine the 
orientation of the insert. Antisense cRNAs were transcribed incorporating DIG-UTP (DIG RNA 
labelling mix Roche). For synthetic mRNA injection, the full length sequence of Polr3g and Polr3gL 
was amplified from cDNA derived from mixed staged X.tropicalis embryos, and directionally cloned 
into pCS2
+
 incorporating an HA tag at the amino terminus. The plasmids were linearised and 
transcribed using Ambion MessageMachine. Synthetic mRNAs coding for FGF4 and Wnt8 were 
generated and injected as in (Burks et al., 2009). 
Whole-mount in situ hybridization 
In situ hybridization was carried out according to Harland (Harland, 1991) with some modifications. 
Vitelline membranes were removed manually from X.tropicalis embryos using forceps. Embryos 
were fixed in MEMFA (0.1M MOPS pH7.4, 2mM EGTA, 1mM MgSO4, 3.7% formaldehyde) for one 
hour and stored in 100% methanol at -20˚C until use. Embryos were rehydrated through a series of 
washes of a gradient of methanol/PBS-Tween (75% methanol/ 25% PBST, 50% methanol/ 50% PBST, 
100% PBST and permeabilised with 10ug/ml Proteinase K (Roche), treated with 
triethanolamine/acetic anhydride, and washed extensively in PBST before refixing in 10% 
formaldehyde. Embryos were then transferred into 50% PBSAT/ 50% hybridization buffer (50% 
formamide, 5X SSC, 1mg/ml total yeast RNA, 100µg/ml heparin, 1X Denharts, 0.1% Tween-20, 0.1% 
CHAPS, 10mM EDTA) at 60˚c for 10 minutes. The solution was replaced with 100% hybridization 
buffer and embryos were prehybridised for 2 hours at 60˚c. Embryos were then transferred into 1ml 
hybridization buffer + 2-3µl DIG probe and rocked overnight at 60˚C. The following day, embryos 
were washed at 60˚C in 2X SSC + 0.1% Tween-20, then 0.2X SSC + 0.1% Tween-20, before blocking at 
room temperature in Maleic Acid Buffer (MAB: 100mM maleic acid, 150mM NaCl, 0.1% Tween-20 
pH7.8) + 20% heat treated lamb serum + 2% Roche Blocking Reagent for two hours. This was 
replaced with fresh blocking solution containing a 1:2000 dilution of affinity purified anti-DIG 
fragments coupled to alkaline phosphatase (Roche) and rolled overnight at 4˚C. Embryos were 
washed three times for one hour in MAB before adding the AP substrate BM Purple™ staining 
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solution (Roche) and left at room temperature until colour developed. Embryos were fixed in 10% 
formalin and photographed. 
Western blotting 
For analysis of protein expression both endogenous and overexpressed, 20-25 X.tropicalis embryos 
were collected and homogenised in 30µl PhosphoSafe™ Extraction Reagent by pipetting. 5µl of 7X 
cOmplete™, Mini EDTA-free Protease Inhibitor cocktail (Roche) was added to the mix and embryos 
were immediately incubated at -80˚c for 10 minutes. Samples were centrifuged at 13,000rpm for 20 
minutes, the resulting supernatants were collected into new tubes and boiled at 95˚c for 5 minutes 
in sample buffer before loading onto 15% Acrylamide SDS PAGE gels. For detecting endogenous 
Polr3g a custom antibody (Eurogentec) was raised against the epitope EIEAERKLQREWT, affinity 
purified, and used 1:10,000  in 5% milk in PBST. Antibodies to GAPDH (Sigma), and HA (Sigma) were 
used under the same conditions at 1:10,000 and 1:1000 respectively. 
  
Total RNA extraction  
For extraction of total RNA from tissue samples, 10-15 embryos/20 explants were snap frozen using 
dry ice. Frozen samples were homogenised in 1ml Tri-Reagent (Sigma), centrifuged 10 minutes at 
13,000rpm to remove yolk and transferred to a new tube. Phase separation with the addition of 
200µl chloroform and centrifugation at 13,000rpm, was followed by isopropanol precipitation of the 
aqueous phase. Samples were centrifuged at 13,000rpm for 10 minutes to pellet the RNA, which was 
resuspended in 40µl of nuclease free water. RNA was then DNAased and purified using the Zymo-
Spin™ Clean and Concentrator™ Kit as per the manufacturer’s instructions to ensure inclusion of 
small RNAs. 
qPCR 
cDNA was synthesised using 1µg of RNA and Superscript IV (Thermo-Fisher) as per manufacturer’s 
instructions with random hexamers. Primers were designed using Integrated DNA Technologies 
PrimerQuest tool. Products were designed to be between 75 and 110 base pairs in length and 
primers were designed across exon junctions to prevent amplification of any residual genomic DNA 
(a table listing all primers is provided in the supplementary data). For qPCR, Fast SYBR Green was 
used in triplicate for three biological repeats. Average Ct was normalized to the housekeeping gene 
Dicer and pairwise t-tests were carried out comparing the mean relative expression for control and 
experimental sets (siblings) for each gene. When more than two conditions were compared, ANOVA 
analysis was carried out. Graphs were constructed in GraphPad Prism5. Error bars represent SEM, * 
= p<0.05, ** = p<0.01. 
 
Microarray design and analysis 
 
To analyse global tRNA expression dynamics in Xenopus, a custom microarray was designed to 
include probes for all tRNA isoacceptor families. Five 60mer probes were designed for each tRNA 
isoacceptor family passing quality checks using Agilent eArray software. Additional manual probes 
were designed for 5’, 3’ and middle sections of isoacceptor family sequences not included in the 
Agilent design. As a control for specificity, sequences for CHO and human tRNA isoacceptor families 
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were also manually designed. A total of 2058 probes were selected for Agilent’s standard 8X15K 
array design; in order to fill the array the probes were replicated 7 times. RNA was extracted from 
embryos as described above and quality control was carried out using the Agilent Bioanalyzer 2000 
to determine RNA Integrity Numbers (RINs between 7.4-7.9). cDNA was labelled with Cy3, hybridised 
on the array for 17 hours at 65°c, washed and scanned to create a high resolution TIFF file for 
processing of expression data. The results from our microarray analyses have been deposited on 
ArrayExpress (www.ebi.ac.uk/arrayexpress) accession numbers are: E-Mtab-7735 (NF stage 9); E-
Mtab-7736 (NF stage 25); and E-Mtab-7752 (FGF/WNT). 
  
GraphPad Prism5 software was used for statistical tests (paired t-tests) on the mean fold change for 
each isoacceptor family and each amino acid isotype for paired samples, and to construct graphs of 
mean fold changes using a threshold of 1.2 and 0.8 for up/downregulation of transcription of tRNA 
families. Graphs include error bars indicating SEM and * indicates the level of significance from the 
statistical analyses after Bonferroni Correction.  To determine 'codon usage scores’,  the number of 
times a codon appears in the coding sequence of all mRNAs included on the microarray was 
calculated and multiplied by the intensity value for that mRNA.  A sum of these values was 
calculated for each mRNA with an intensity value of above 10, and graphed against tRNA expression 
values measured as their intensity values on the array. Correlation was calculated using Spearman’s 
Rho assessment for monotonic relationship between variables. Correlation coefficients between 0 
and 1 were calculated and p-values presented. 
 
Results   
Expression of POLR3G isoforms 
 
Temporal profiling of Polr3g and Polr3gL expression in X.tropicalis reveals a complementary 
expression pattern where high levels of Polr3g transcripts are detected in the early embryo, while 
Polr3gL is not detected until later (Figure 1). During vertebrate development, the earliest cleavage 
stages are characterised by rapid cell division and are supported by stored maternal mRNA and 
proteins while the zygotic genome is silent until a point called the midblastula transition (MBT, 
between NF stage 8 and 9) when the cell cycle lengthens and zygotic transcription begins. We have 
found that Polr3g transcripts and protein are present prior to MBT and later fall to a lower level, 
while in contrast, Polr3gL transcription is activated after MBT and increases during early 
development. Figure 1A shows a semi-quantitative RT-PCR where Polr3g expression is highest 
maternally, during early cleavage, prior to MBT. After the activation of embryonic transcription, 
Polr3g expression decreases rapidly and Polr3gL expression is activated. Western blotting 
demonstrates Polr3g protein expression is highest in embryos prior to MBT, however, a low level of 
protein persists into later developmental stages suggesting that Polr3g protein is relatively stable in 
vivo (Figure 1B). Interrogating an RNA-seq database available online (www.xenbase.org) provides 
additional data consistent with our findings that Polr3g and Polr3gL have a complementary 
expression during Xenopus development. (Figure 1C (Owens et al., 2016)) .  
To determine the spatial localisation of Polr3g isoforms during development, we used in situ 
hybridization to analyse endogenous gene expression in a stage series of X.tropicalis embryos (Figure 
2 and 3; also see supplementary Figures 1 and 2).  We find a remarkable, specific expression of 
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zygotic Polr3g in the early somites (Figure 2A-C), the source of all skeletal muscle in the vertebrate 
body. Polr3g is expressed in the muscle forming region from neurula stages while the analysis of 
later embryos reveal that this expression is transient as by late tailbud stages Polr3g is no longer 
expressed in the somites, but rather it is expressed in the pronephros and the eye (supplemental 
data). In contrast, Polr3gL is not expressed in the somites at this stage, but rather in the eye, neural 
tube and branchial arches (Figure 3A). At later stages, Polr3gL continues to be expressed at high 
levels in the head and the ventral blood island, and in the posterior somites (Figure 3C and D). To 
further assess the specificity of Polr3g isoform expression in the somites, RNA was extracted from 
dissected sections of NF stage 23 (Head, Ventral and Dorsal). Quantitative RT PCR analysis (qPCR) 
confirmed the enrichments of Polr3g transcripts in the dorsal, somitic region of the early embryo 
(Figure 2D), while at this same stage Polr3gL transcripts are found both anteriorly and dorsally 
(Figure 3B), consistent with its expression in the head and neural tube at this stage.  
Measuring Pol III activity 
 
Among other targets, RNA polymerase III (Pol III) transcribes the tRNA genes, and there are 
challenges in analysing the transcription of these small, highly structured RNAs. Antibodies against 
Pol III have been used for ChIP-seq, identifying different tRNA genes that are active in different cells 
(Schmitt et al., 2014). These studies were carried out in mammals that have 400-600 tRNA genes 
compared to the 2638 tRNA genes in the X.tropicalis genome (http://gtrnadb.ucsc.edu/).   The 
extensive repetitive nature of almost identical tRNA sequences in Xenopus would make the 
computational analysis downstream of ChIP-seq problematic. We therefore opted to directly assess 
the tRNA transcriptome, which has challenges of its own because of the highly-modified nature of 
tRNAs. Reverse transcriptase based protocols that rely on the priming and extension of the first 
strand cDNA are not very efficient on tRNAs; for instance, high throughput sequencing methods only 
work when samples are pre-treated with demethylases for DM-tRNA-seq (Zheng et al., 2015). We 
observed these phenomena when preparing cDNA from a stage series of early Xenopus embryos: 
using RT-PCR, we detected no tRNAs in cDNA prepared from samples prior to mid-blastula transition 
(MBT), the point when the zygotic genome initiates transcription (Supplementary Figure 3A). Clearly, 
tRNAs are present in early frog embryos and oocytes that readily produce protein from injected 
mRNAs, and this artefact is due to a failure of cDNA synthesis from highly structured tRNAs. The 
denaturing conditions of Northern blotting reveals the high expression of the mature tRNA 
transcripts for Tyrosine throughout the stages examined (73nt) (Supplementary Figure 3B). The 
newly synthesised transcripts are discernible as unprocessed 103nt and 86nt transcripts and 
detected after MBT; this is the same time point when it is possible to detect tRNA by RT-PCR. We 
conclude that newly transcribed tRNAs that are activated in Xenopus at MBT (Newport and 
Kirschner, 1982b) and native tRNA transcripts from active transcription can be analysed using cDNA-
based methods. 
 
Polr3g has differential effects on transcription of tRNA isoacceptors upregulating a subset of mRNAs  
Large-scale analysis of transcriptional changes as a response to Polr3g overexpression was 
undertaken using a custom microarray (Agilent) that includes probes for tRNAs and other RNA 
polymerase III targets, as well as selected mRNAs. Multiple tRNA anticodon families (isoacceptors) 
encode each amino acid isotype and the different isoacceptor families reflect the redundancies in 
the translational code. For instance, methionine has only a single anticodon tRNA Met
CAT
, while 
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arginine has six different and partially redundant tRNA anticodons recognised by a family of 
isoacceptors: tRNA Arg
ACG
, Arg
GCG
, Arg
CCG
, Arg
TCG
, Arg
CCT
 and Arg
TCT
.  In Xenopus there are 54 
isoacceptor families encoding the 20 standard amino acid isotypes and each anticodon isoacceptor is 
encoded by multiple tRNA genes. In Xenopus tropicalis, it is estimated that there are 2638 tRNA 
genes (Chan and Lowe, 2016) where gene duplication means that the expression analysis of 
individual tRNA genes is impossible using hybridization or primer-based methods. Therefore our 
data on the regulation of tRNA expression is analysed at the level of the isoacceptor family (codon 
specific) rather than at the level of individual tRNA genes. 
 
To determine whether Polr3g overexpression has an effect on tRNA expression during development, 
2ng of synthetic mRNA coding for Polr3g was injected into X.tropicalis embryos at the 2-cell stage 
cultured until just after MBT (NF stage 9). RNA was extracted from three biological repeats of Polr3g 
injected and paired sibling control embryos, and labelled cDNA was hybridised to the array. Analysis 
of both mean fold change and differences between the means of control and experimental samples 
were carried out for tRNAs at the level of isoacceptor and amino acid isotype and summarised in 
Figure 4. Fold changes of the mean normalized expression for each anticodon family are shown with 
fold change thresholds of 0.8 and 1.2 were used to define families as downregulated or upregulated 
respectively. Polr3g injected samples showed significant differences in tRNA expression levels for 
many isoacceptor families when compared to control samples.  Overall more isoacceptor families 
are upregulated than are downregulated as a result of Polr3g overexpression. In addition, Polr3g 
activity in blastula embryos results in distinct changes in expression of some isoacceptor families 
(Figure 4A). For instance, tRNA
Gln
 has two isoacceptor families present at Stage 9 and while Gln
CTG
 is 
significantly upregulated by overexpression of Polr3g, expression of Gln
TTG
 is decreased to 0.64 
relative to control expression levels. A similar change in expression occurs in tRNA
Thr 
families.   tRNA
Ser 
isoacceptor families show variable regulation by Polr3g; Ser
AGA
 and Ser
GCA
 families 
show no change in expression, Ser
GCT
 is significantly upregulated and Ser
TGA
 is significantly down-
regulated in embryos overexpressing Polr3g. We find that complementary changes in expression of 
other tRNA isoacceptor genes equilibrates the overall level of tRNAs for each amino acid isotype 
(data not shown), consistent with a previous study (Schmitt et al., 2014).  Interestingly, other RNA 
polymerase III genes (both 5S rRNAs, 7SK and 7SL RNAs) were significantly downregulated in samples 
overexpressing Polr3g compared with control embryos, while another Pol III target, U6 RNA, 
appeared to show some level of upregulation (Figure 4B). We conclude that Polr3g activity can 
differentially regulate a subset of tRNA isoacceptor families and other Pol III genes during early 
development and can selectively activate, and occasionally repress transcription.  
 
Several mRNAs selected for analysis are expressed at higher levels in embryos overexpressing Polr3g 
compared to sibling controls. mRNAs shown to be significantly upregulated include a number of key 
regulators of early embryonic patterning (Figure 4C):  the BMP antagonist chordin (chrd), the 
forkhead box transcriptional repressor foxd5; the bHLH transcriptional repressor id3; wnt8a, a ligand 
involved in ventral mesoderm patterning; the Spemann Organiser transcription factor (gsc); a 
mesodermal factor, eomesodermin (eomes); theTGFb ligand nodal (xnr4); and the nodal inhibitor, 
lefty.  The mechanism by which this Pol III subunit affects Pol II gene transcription is unknown, but 
similar observations where overexpression of Polr3g results in changes in mRNAs have been 
described elsewhere (Lund et al., 2017).  
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 Differential regulation of tRNAs by Polr3g and Polr3gL.  
Given the specific expression of Polr3g in the somites at early tailbud stages, and Polr3gL in later 
myogenesis, we wanted to determine the effect of overexpression of Polr3g as compared to Polr3gL 
on the synthesis of tRNAs in the muscle lineage. To do this, embryos were injected at the 2-cell stage 
with 2ng of synthetic mRNA coding for either Polr3g or Polr3gL and the dorsal regions dissected at 
Stage 25 for analysis. At this stage, the somites present in the dorsal region express MyoD and these 
cells are committed to the skeletal muscle lineage. Expression constructs included an HA tag to 
monitor levels of protein resulting from overexpression and western blot analysis shows that equal 
amounts of Polr3g and Polr3gL were present in all three biological replicates (Figure 5A).  Dorsal 
regions were collected as illustrated in Figure 5B and qRT-PCR analysis for expression of MyoD 
confirmed accurate dissections (data not shown). Labelled cDNA was hybridised to custom 
microarrays as described in methods. 
In contrast to the ability of Polr3g to activate tRNA synthesis at blastula stages, Polr3g shows very 
little activity in this more differentiated tissue (Figure 5C).  Polr3gL, in contrast, represses 
transcription of tRNAs when overexpressed in dorsal lineages (Figure 5D). Figure 5C and 5D 
summarize the expression of tRNA isoacceptor families expressed above a threshold values of 10 in 
response to overexpression of Polr3g and Polr3gL. Polr3g overexpression results very few significant 
changes to tRNA synthesis.  Polr3gL overexpression downregulates some isoacceptor families; for 
instance, all tRNA
Ala
 families, Arg
TCG
 , Ile
AAT
, Leu
CAA
 , Leu
AAG
 and Ser
GCT
. Overexpression of Polr3gL 
results in significant upregulation of Tyr
GTA
, and no significant changes to tRNA
Val
 families, while 
Polr3g overexpression results in no change in Tyr
GTA
 but significant upregulation of Val
AAC
 and Val
CAC
 
at this stage.  
In order to generate an overview of any distinct transcriptional effects of Polr3g and Polr3gL 
overexpression in this tissue, a scatterplot of these data was used to compare normalised expression 
of tRNA isoacceptors in samples overexpressing each factor.  In Figure 5E, the X-axis shows 
expression of tRNA isoacceptors in Polr3g samples and the Y-axis shows their expression in Polr3gL 
samples. The dashed lines delineate a 2-fold change in expression and all points lie within these 
margins suggesting no significant difference between the samples.  The overall effect of 
overexpression of Polr3gL at this stage is to down regulate tRNA synthesis, while Polr3g shows little 
activity at this stage (Figure 5E). 
Our expression analysis indicates that Polr3gL is expressed during myogenic differentiation, 
replacing the transient expression of Polr3g, suggesting Polr3g and Polr3gL have distinct activities 
during myogenic differentiation. We investigated whether the overexpression of Polr3g or Polr3gL 
leads to changes in the expression of any myogenic genes in St25 dorsal regions and found that 
several contractile protein genes were found to be significantly upregulated in dorsal regions 
overexpressing Polr3gL, while unaffected by Polr3g (Figure 5F). 
Correlation of tRNA abundance with codon usage in skeletal muscle specific genes 
 
Previous studies have correlated tRNA expression with mRNA codon usage in specific tissues 
(Dittmar et al., 2006; Gingold et al., 2014). To assess this relationship in vivo during skeletal muscle 
development, Codon Usage Estimate values were calculated by multiplying codon usage of mRNAs 
by their gene expression value and this value is plotted on the x-axis.  For blastula stage 9, codon 
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usage was calculated for all transcribed mRNAs while for stage 25 explants, we focussed on the 
contractile protein mRNAs that were included on the arrays. Codon usage is compared to tRNA 
anticodon isoacceptor intensity using values from the array as a measure of tRNA expression (y-axis) 
(Supplemental Figure 4). Spearman’s correlation analysis was carried out on the microarray 
expression data from control samples at Stage 9 for all tRNAs and expressed mRNAs, not assuming a 
linear relationship. The scatterplots shown in supplemental data indicate a weak correlation (0.175) 
between tRNA expression and mRNA codon use at stage 9, when cells remain in an undifferentiated 
state.  At NF Stage 25, a time when muscle genes are activated in these dorsal samples, the data 
indicate a moderate correlation (0.349), suggesting that tRNA transcription is increasingly regulated 
to match mRNA codon usage during the establishment of the skeletal muscle lineage. This is 
consistent with the theory that regulatory mechanisms exist to stabilise the ‘mRNA-tRNA’ interface 
suggested by other researchers (Dittmar et al., 2006; Gingold et al., 2014; Hentzen et al., 1981).  
Pol III activity is downregulated during myogenic differentiation 
To test the possibility that there is a muscle specific tRNA profile in Xenopus, we exploited an explant 
model of myogenic differentiation. Overexpression of FGF4 alone in animal hemisphere explants is 
sufficient to induce a change in cell fate such that the tissues develops as largely ventral-type 
mesoderm (Slack et al., 1987). The induction of dorsal mesoderm (and muscle in particular) is 
enhanced through the co-injection of Fgf4 with Wnt8 (Burks et al., 2009). To test the existence of a 
myogenic-specific tRNA profile, this model of myogenic differentiation in animal caps was analysed 
by microarray.  
Embryos were injected in the animal hemisphere of both blastomeres at the two-cell stage with 
synthetic mRNA coding for FGF4 (5pg) and Wnt8 (50pg). Explants from injected and sibling control 
embryos were taken at blastula stage 8 and cultures until NF stage 25 for RNA extraction. Sibling 
explants were cultured until NF stage 40 and the differentiation of skeletal muscle was confirmed by 
histology (not shown). Three biological repeats comprise 15 explants for each experimental and 
paired control sample were used to generate labelled cDNA and hybridised to our custom tRNA 
microarray. Strikingly, when compared to controls, all tRNA isoacceptor families detected on the 
microarray showed a significant reduction in response to Fgf4 and Wnt8 signalling (Figure 6A). In 
addition, all other RNA Polymerase III target genes were also significantly downregulated in 
experimental samples, indicating an overall down-regulation of RNA Polymerase III transcriptional 
activity in response to these myogenic inducing signals. Pol III activity  was also found to be 
downregulated in vivo during differentiation, as the stage 25 dorsal explants show reduced 
transcription of tRNAs compared to blastula embryos (Supplemental Figure 5). 
In contrast, the expression of contractile protein genes and the myogenic regulatory factor (MRF) 
genes are dramatically upregulated in Fgf4/Wnt8 caps (Figure 6B and C). Notably, the embryonic 
isoform of α-actin, actc1, was upregulated indicating that the muscle lineages induced were in the 
early stages of differentiation. Analysis of MRF gene expression shows that the early regulator Myf5 
was upregulated in response to Fgf4 + Wnt8 with a mean fold change of 69.6, as was MyoD (fold 
change of 23.9). Mrf4 and Myogenin, factors more associated with terminal differentiation, were 
less highly upregulated (fold change 12.4 and 6.4 respectively). These data are consistent with gene 
expression in cells early in the process of muscle lineage differentiation. 
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Genes coding for cell cycle associated proteins (Ccne1, Ccne2, Mycl and Mycn) were also upregulated 
in response to Fgf4 + Wnt8, and the expression of the cell cycle inhibitor p27kip1 was significantly 
downregulated (Figure 6D). These data indicate that our myogenic explants retain cells that are 
proliferative, however, markers of pluripotency such as Klf4, Klf6, Myc and Aurka are either 
unchanged or down-regulated in these same samples. This suggests a loss of pluripotency during 
lineage determination and differentiation; indeed, determined myoblasts expressing Myf5 and 
MyoD are still proliferative despite their commitment to a myogenic fate (Emerson, 1990;  Pownall 
et al., 2002).  
Down-regulation of the Polymerase III transcription machinery during differentiation  
To determine a possible mechanism for the downregulation of RNA Polymerase III transcription in 
response to myogenic inducing signals, we analysed the expression levels of Pol III subunits and 
associated transcriptional machinery in response to FGF/Wnt (Figure 6E). Notably, the components 
of the TFIIIB complex, Brf1 and Bdp1, are significantly downregulated in our experimental samples. 
These factors are known to be important for Pol III transcription initiation and have been implicated 
in the regulation of RNA Polymerase III transcription during differentiation (Athineos et al., 2010).  
The majority of RNA polymerase III subunits are downregulated in response to the initiation of 
muscle differentiation, with the exception of Polr3A and Polr3C (unchanged), and Polr3K and Polr3gL 
(increased) (Figure 6E). Polr3gL is associated with differentiation, and the upregulation of this 
isoform in response to muscle differentiation induced by FGF/Wnt is expected. Polr3g in contrast is 
not induced in this model of myogenesis despite its specific, transient expression in the early 
somites.  
Polr3g overexpression can reverse some aspects of myogenic differentiation 
Polr3g is associated with proliferative pluripotent cells and its expression is unchanged in our explant 
model of myogenic differentiation, however we nonetheless find elevated expression of some 
markers of proliferation. Our interpretation is that the population of proliferative cells in FGF/Wnt 
explants are no longer pluripotent, but rather are committed to the skeletal muscle cell lineage. The 
presence of Polr3g in early somites (Figure 2) suggests an early role in the muscle lineage, so we 
tested the ability of Polr3g to reverse the effects of myogenic induction on transcription by injecting 
mRNA coding for Polr3g in combination with FGF4 and Wnt8. We used qPCR to analyse a set of 
tRNAs isoacceptors and mRNAs coding for muscle proteins. Figure 7 shows the relative fold changes 
of expression of experimental versus paired control explants. Our data indicate that Polr3g 
overexpression is not sufficient to rescue the downregulation of a set of tRNA isoacceptors (Figure 
7A) that is also observed in the microarray analysis in reponse to FGF/Wnt induction (Figure 6A). 
Surprisingly, overexpression of Polr3g did result in the downregulation of the FGF/Wnt induction of 
skeletal muscle differentiation markers (Figure 7B). Control explants do not express contractile 
protein genes, so the fold increase observed in FGF/Wnt treated explants is very large (values 
ranging from an average of 1600 to 125,000 fold increase) and we set these values to 1. When 
Polr3g is co-expressed with FGF4 and Wnt8, the explants show reduced expression of these 
differentiation genes. actc1 is decreased to 14%,  act3 is decreased to 7% and myh4 is decreased to 
15% of the levels of gene expression  activated by FGF4 and Wnt8. This finding that Polr3g 
expression is at least in part incompatible with cell differentiation is consistent with a previous study 
in ESCs showing that Polr3g overexpression results in a resistance of ESCs to respond to 
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differentiation by retinoic acid (Wong et al., 2011).  We show here that Polr3g is not sufficient to 
rescue differentiation-induced restriction of Pol III transcriptional targets. This may be due to the 
transcriptional down regulation of essential co-factors Brf1,2 and Bdp1 (Figure 6E). Polr3g expression 
can nonetheless inhibit aspects of FGF/Wnt induced cell differentiation resulting in the decrease of 
skeletal muscle specific mRNAs.  
 
Discussion 
Tissue specific expression of transcription factors is a common theme in developmental biology, 
where families of transcriptional regulators (eg, the bHLH myogenic regulatory factors) drive cell fate 
determination and differentiation. However, the restricted pattern of expression of basal 
transcriptional machinery, specifically the Polr3g and Polr3gL subunits of RNA polymerase III, during 
embryonic development is a novel finding. The documented role for the Polr3g-containing isoform 
of Pol III in proliferative, pluripotent cells (Wong et al., 2011; Haurie et al., 2010) suggests that the 
localised expression we show in embryos points to Polr3g expression in progenitor cells. The 
transient nature of Polr3g expression, from paraxial mesoderm and somite (early skeletal muscle 
lineage) to pronephric tubules (early kidney lineage) is consistent with its regulation during cell fate 
progression.  The overall levels of Polr3g transcripts and protein are low subsequent to the early 
cleavage stages that are characterised by rapid cell division; however, western blotting and RT-PCR 
show that it is not entirely absent, and in situ hybridization analysis reveal highly regulated 
expression of Polr3g during development. The alternative isoform, Polr3gL is transcribed only 
zygotically and its expression is enriched in the developing nervous system, including the otic vesicle 
(developing ear) and branchial arches (derived from neural crest), as well as the ventral blood island. 
Its later expression in the differentiating somites is consistent with our findings that Polr3gL is 
expressed in response to myogenic induction in an explant model. Overexpression of Polr3gL results 
in downregulation of Pol III transcription in dorsal regions and upregulation of skeletal muscle 
specific genes, similar to the effects of myogenic induction. In contrast, Polr3g overexpression had 
some ability to reverse differentiation. The lack of overlap of the timing and the tissue specific 
expression of Polr3g isoforms indicates these genes are differentially regulated during development, 
this, together with their distinct activities suggest different, possibly sequential roles in myogenic 
determination and differentiation. 
 
Analysing RNA polymerase III transcription in Xenopus 
To investigate any differential activity of Polr3g isoforms we analysed Pol III transcription in 
overexpression assays; our attempts at knockdown and gene targeting were unsuccessful due to the 
large amount of maternally deposited Polr3g mRNA and protein present in early embryos. Another 
consideration when considering this work is the large expansion of tRNA genes in Xenopus;  the 
repetitive nature means that identifying any change in expression of any individual tRNA gene is not 
possible. By using a custom tRNA microarray we have been able learn about the transcriptional 
activity of sets of tRNA isoacceptors and isotypes.  An alternative approach would be RNAseq 
following the methods of (Zheng et al., 2015) that uses methylase treatment to improve cDNA 
synthesis of tRNAs. This method disrupts tRNA structure to allow access to the polymerase during 
first strand synthesis for cDNA production, which make high throughput sequencing protocols 
possible for tRNA.   
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We found that Polr3g activity does not lead to uniform upregulation of Pol III targets, as may have 
been predicted from the presence of Polr3g in transformed cells (Haurie et al., 2010) and the 
upregulation of Pol III activity in cancer cells (Khattar et al., 2016). Instead, we find restricted sets of 
tRNA isoacceptors that are either up- or down-regulated at the start of transcription (Figure 4) or 
differentially effected at two different stages. For example, Polr3g overexpression upregulates 
tRNA
Ala
 and tRNA
Leu
 families at NF Stage 9 but not at NF Stage 25. The ability to activate or repress 
different target genes at different stages and regions suggests that Polr3g may have different 
transcriptional activity during development. These changes in Pol III transcriptional activity can result 
from interactions with co-factors or the influence of signal transduction pathways (reviewed (White 
and Sharrocks, 2010)). Polr3g is known to interact with Polr3C(RPC62) (Boissier et al., 2015) as part 
of a ternary complex with Polr3F (RPC39) essential for activating of transcription of target genes 
(Wang and Roeder, 1997). RNA Polymerase III is regulated by a number of developmental signalling 
pathways (Erk, TOR) and cellular regulators (p53, Rb, Myc, Maf1) which alters its activity in vitro 
(Felton-Edkins et al., 2003). It is well documented that dynamic signalling during development drives 
cell specification and determination by regulating Pol II activity, and we suggest here that Pol III 
activity is also disposed to regulation by cell signalling, providing an explanation for the differential 
effects of Polr3g activity in blastula and later stages of development.  
 
Some RNA Polymerase II targets are upregulated in blastula embryos overexpressing Polr3g. 
 
It is surprising that overexpression of Polr3g results in the selected upregulation of a few RNA 
Polymerase II regulated genes with roles in early development (Figure 4C). While other studies have 
indicated that Polr3g overexpression can upregulate RNA Polymerase II genes involved in 
pluripotency, this has been attributed to an indirect effect of Polr3g expression enhancing resistance 
to differentiation programmes in ESCs (Wong et al., 2011), which is not the case in these early 
embryos. We suggest an alternative mechanism, the shifting of the MBT, to explain the observation 
that Polr3g overexpression results in changes to RNA Polymerase II target genes in early Xenopus 
embryos. The genes identified as upregulated in embryos overexpressing Polr3g are early 
developmental regulators, normally transcribed just after MBT.  MBT is preceded by rapid 
synchronous cell divisions known as cleavage during which embryos do not increase in size and, as a 
consequence, cells become smaller through consecutive divisions (Newport and Kirschner, 1982a). 
Previous studies in Xenopus have shown that MBT is triggered by the increase in Nuclear : 
Cytoplasmic (N:C) ratio; this mechanism is explained by the titration of limiting replication factors 
that are diluted during the rapid cell divisions and when reduced to a sufficient level, the cell cycle 
slows and zygotic transcription begins (Collart et al., 2013), (Newport and Kirschner, 1982a). It is 
possible that overexpression of Polr3g in Xenopus results in increased rates of cell division, raising 
the N:C ratio, and allowing the precocious activation of transcription of zygotic transcripts as MBT is 
brought forward (Figure 4).  Cell culture studies have indicated that Polr3g increases cell 
proliferation rates in cancer cell lines and increased tumour growth (Khattar et al., 2016).  In human 
ESCs, Polr3g expression results in increased levels of cell cycle regulators Aurora Kinase A and Cyclin 
E and the maintenance of pluripotency factors (Haurie et al., 2010), (Wong et al., 2011).  
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Polr3g expression in the myogenic lineage 
We demonstrate here for the first time that different isoforms of RNA polymerase III are present in 
distinct cell lineages during vertebrate development. The specific expression of Polr3g in early 
somite cells likely marks a transient population of proliferative cells at an early stage during lineage 
determination. Our FGF/Wnt induction of myogenesis did not capture this time point, but instead a 
later point after the onset of expression of Polr3gL and other early differentiation markers (eg. myh, 
actc). Overall the ability of Polr3g to increase Pol III activity, together with its known presence in 
proliferative cells including Xenopus oocytes and pre-MBT embryos, suggests a role in augmenting 
levels of Pol III transcripts, ensuring sufficient tRNAs and other small RNAs as cell numbers increase. 
The specific yet transient expression of Polr3g in the early somites points to a progenitor population, 
still proliferative yet committed to the skeletal muscle cell lineage. Polr3gL is expressed during 
myogenic differentiation (and in other differentiating lineages), and its expression is associated with 
the decrease in Pol III activity, as seen in our explant study. It is worth noting that the pluripotency 
markers Sox2 and Oct4 are upregulated in explant model of myogenesis (Figure 6 D).  This is not 
surprising given that the dorsal mesoderm induced by Wnt/FGF itself induces neural tissue which 
expresses both Sox2 and Oct4, therefore it is not possible to draw any conclusions from this 
experiment in terms of pluripotency.  
 
Nevertheless, we found a remarkable association of decreased Pol III activity during differentiation 
that could not be reversed by overexpressing Polr3g. This progressive down-regulation of Pol III 
transcription is also evident when comparing endogenous levels of Pol III transcripts at blastula 
stages with that of tailbud explants (supplemental data). Downregulation of Pol III activity has been 
observed previously during the differentiation of F9 carcinoma cells and was shown to be due to 
reduced levels of the TFIIIB subunits Brf1 and Bdp1 (Athineos et al., 2010; White et al., 1989). Here, 
we extend candidates involved in the mechanism downregulating Pol III activity to much of its 
transcriptional machinery. The overexpression of Polr3g alongside Fgf4/Wnt8 in animal caps was not 
sufficient to reverse the downregulation of Pol III tRNA targets upon myogenic differentiation. This 
may be due to the high expression of Polr3gL at this stage competing with and overcoming Polr3g 
occupancy at target gene promoters. However, Polr3g expression did result in a significant reduction 
in the activation of muscle genes suggesting that, as in ESCs (Wong et al, 2011), Polr3g is able to 
increase resistance of cells to fully differentiate in the presence of inducing signals.  
 
It is interesting to note recent findings that demonstrate Pol III regulation of microRNA transcription 
by a C/EBPβ-mediated activation of a tRNA-like enhancer element in miR-138 (Di Pascale et al., 
2018).  Since C/EBPβ restricts myogenic differentiation in satellite cells (Lala-Tabbert et al., 2016), 
and it is well known that MyomiRs are important players in myogenesis (Horak et al., 2016), these 
types of interactions could underlie our observed differential effects of Pol III isoforms on Pol II 
transcription.  Overall, our findings attest to the importance of considering the activity of RNA 
polymerase III when building gene regulatory networks to describe myogenic differentiation. 
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Figure Legends 
 
Figure 1  Temporal expression analysis of Polr3g and Polr3gL expression during Xenopus tropicalis 
development. (A) RT-PCR analysis of Polr3g and Polr3gL mRNA expression across a stage series of 
X.tropicalis development. 28S rRNA was used as an endogenous control. (B) Western blotting of 
protein extracts from a stage series of X.tropicalis embros using an antibody generated against 
X.tropicalis Polr3g. GAPDH was used as a loading control. (C) Meta analysis of RNA-Seq data for 
Polr3g and Polr3gL across Xenopus development carried out by Owens et al. (2016) and deposited 
online via Xenbase.org. 
 
Figure 2 Expression of Polr3g in Xenopus tropicalis embryos.  Expression analysis of Polr3g Xenopus 
tropicalis at NF stage 20. (A) Lateral view of NF St20 embryo analysed by in situ hybridization for 
Polr3g; expression in the somites is indicated; anterior is to the left. (B) qRT-PCR for Polr3g 
expression in the early tailbud (NF St23). Head, Ventral and Dorsal sections were dissected and RNA 
extracted for qPCR. Ct values were normalised to the gene Dicer. All expression values were 
calculated relative to somite expression. One-way ANOVA statistical analysis was carried out on 
relative expression of each section for each gene (*) represents the level of significance. (C) Dorsal 
view of NF St20 embryo analysed by in situ hybridization for Polr3g; a cross-section through the 
embryo shown in (D) is indicated; anterior is to the left.  (D) Cross section of embryo shown in (C) 
shows specific expression of Polr3g in somites at NF St20. 
 
Figure 3 Expression of Polr3gL in Xenopus tropicalis embryos. Expression analysis of Polr3gL 
Xenopus tropicalis at NF stage 20. (A) Lateral view of NF St20 embryo analysed by in situ 
hybridization for Polr3gL; expression in the anterior neural tube (nt), otic vesicle (ov), and branchial 
arches (ba) is indicated; anterior is to the left. (B) qRT-PCR for Polr3gL expression in the early tailbud 
(NF St23). Head, Ventral and Dorsal sections were dissected and RNA extracted for qPCR. Ct values 
were normalised to the gene Dicer. All expression values were calculated relative to somite 
expression. One-way ANOVA statistical analysis was carried out on relative expression of each 
section for each gene (*) represents the level of significance. (C) Lateral view of NF St28 embryo 
analysed by in situ hybridization for Polr3gL; expression in the otic vesicle (ov), and branchial arches 
(ba), blood island (bi), and posterior somites is indicated. A cross-section through the embryo shown 
in (D) is indicated; anterior is to the left.  (D) Cross section of embryo shown in (C) shows specific 
expression of Polr3g in posterior somites at NF St28. 
 
Figure 4 Changes in tRNA expression in response to Polr3g overexpression. Expression fold change 
summary of tRNA isoacceptor families in X.tropicalis NF Stage 9 whole embryos injected with 2ng 
Polr3g mRNA compared to control uninjected stage 9 embryos across 3 biological replicates. Signal 
data was processed using GeneSpring to determine normalized signal values for each probe within 
each array, and a normalized intensity reading by comparing probes across the arrays; these values 
were used to determine expression fold changes for each biological replicate to give an average fold 
change for each probe across the three replicates. Control and Polr3g injected mean expressions for 
each of the 5 probes designed per isoacceptor family were then analysed using paired t-tests to 
determine statistical significance of the change in expression for each anticodon isoacceptor family. 
To account for multiple comparisons, Bonferroni Correction was applied. (A) Summary chart of fold 
changes for isoacceptor families with raw signals of >10. Orange indicates significantly up-regulated 
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transcription, blue indicates significantly down-regulated transcription, and pink indicates no 
significant change in expression. SEM is presented as error bars and * indicates the level of statistical 
significance. (B) Summary chart of fold changes for other Pol III target genes with raw signals of >10. 
(C) Summary chart of fold changes for mRNAs upregulated in Polr3g overexpression samples. 
 
Figure 5 Overexpression of Polr3g compared to that of Polr3gL in Xenopus tropicalis embryos. 
 (A) 2ng of mRNA coding for HA-tagged Polr3g and Polr3gL was injected into both blastomeres of 
X.tropicalis embryos at the 2-cell stage and embryos were allowed to develop until NF Stage 25. 
Western blot analysis of injected and control embryos for detection of HA-tag expression shows 
equal levels of protein expression in injected embryos.  GAPDH was used as a loading control. (B) 
Dorsal regions were dissected to enrich for myogenic tissue at this stage of development (labelled 
here by in situ hybridization for MyoD). (C) Expression fold change summary of tRNA isoacceptor 
families in X.tropicalis NF Stage 25 dorsal sections injected with 2ng Polr3g mRNA versus control 
uninjected across 3 biological replicates. (D) Expression fold change summary of tRNA isoacceptor 
families in X.tropicalis NF Stage 25 dorsal sections injected with 2ng Polr3gL mRNA versus control 
uninjected across 3 biological replicates. Orange indicates up-regulated transcription, blue indicates 
down-regulated transcription, and pink indicates no change in expression. SEM is presented as error 
bars and * indicates the level of statistical significance between control and injected samples after 
Bonferroni Correction. (E) Scatterplot comparing normalised expression of tRNA isoacceptor families 
in embryos overexpressing Polr3g compared to those overexpressing Polr3gL. Solid line indicates no 
expression difference. Dashed lines indicate 2 fold change in expression. Polr3g values are on the X-
axis and Polr3gL values are on the Y-axis. (F) Expression fold change summary of selected contractile 
proteins in X.tropicalis NF Stage 25 dorsal sections injected with 2ng of Polr3g (orange) or Polr3gL 
(blue) mRNA versus control uninjected across 3 biological replicates. SEM is presented as error bars 
and * indicates the level of statistical significance between control and injected samples after 
Bonferroni Correction. 
 
Figure 6. Downregulation of Pol III activity in a myogenic explant model.  Overexpression of Fgf4 + 
Wnt8 in NF Stage 25 X.tropicalis animal explants results in a downregulation of RNA Polymerase III 
transcripts and an upregulation of mRNAs associated with myogenic differentiation.  Expression fold 
change summary of X.tropicalis NF Stage 25 animal cap explants dissected from embryos injected 
with 5pg Fgf4 and 50pg Wnt8 mRNA compared to explants taken from control uninjected embryos 
across 3 biological replicates. Only RNAs with raw signal intensities of >10 were included in the 
analyses. (A) RNA Polymerase III target genes (significantly altered tRNA isoacceptor families are in 
blue, other significantly altered RNA Polymerase III targets are shown in red). (B) Contractile protein 
gene expression is highly upregulated (note the log scale). (C) Expression of the Myogenic Regulatory 
Factor (MRF) genes is also upregulated in Fgf4 + Wnt8 explants. (D) Selected genes associated with 
pluripotency and cell cycle regulators are differentially affected in Fgf4 + Wnt8 explants.  (E) 
Overexpression of Fgf4 + Wnt8 in NF Stage 25 animal cap explants results in downregulation of some 
genes coding for proteins associated with RNA Polymerase III core transcription machinery. Pink in 
all panels indicates no significant change in expression, while blue is significantly down and orange is 
significantly up. SEM is presented as error bars and * indicates the level of statistical significance 
between control and injected samples after Bonferroni Correction. 
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Figure 7 Polr3g overexpression restricts myogenic differentiation in an explant model of 
myogenesis without eliciting any recovery of tRNA expression  
 
qRT-PCR analysis of RNA extracted from explants injected with either Fgf4 + Wnt8, or Fgf4+ Wnt8 + 
Polr3g and cultured to stage 25.  (A) Analysis shows a significant decrease in tRNA isoacceptors for 
iMethionine
CAT
, Tyrosine
GTA
 and Alanine
AGC
 in both experimental groups as compared to uninjected 
control explants at stage 25.  Pair-wise t-tests were carried out for each tRNA’s mean relative 
expression comparing the mean Ct values normalised to control gene Dicer, for the three biological 
replicates, between the uninjected controls and the experimental groups. Error bars represent SEM. 
(B) qPCR analysis shows high increase in differentiation specific mRNAs actc1, act3 and myh4 
activated by myogenic inducing factors FGF4+Wnt8.  The mean relative expression of two biological 
replicates was plotted (muscle gene expression is not detectable in un-induced animal caps).  Mean 
fold changes of 3,306 (actc1), 249,870 (act3) and 96,436 (myh4) were found in Fgf4/Wnt8 samples 
and set to 1.0; these were reduced to 14%, 7% and 15% of this level, respectively, when Polr3g was 
co-expressed. Error bars represent SEM. 
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Highlights: 
• There are 2 distinct isoforms of Pol III with either the subunit Polr3g or Polr3gL  
• Polr3g and Polr3gL have complementary expression during development 
• Polr3g is transiently expressed in early somites; Polr3gL is activated later  
• Pol III activity decreases during differentiation, while Polr3gL increases 
• Expression of Polr3g is not compatible with differentiation 
